Aberdeen Group plc

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1716774 EDINBURGH, X0

Position in CRNX

as of Mar 31, 2026 · filed Apr 29, 2026 Compact

Position Value

$29,796,746

-$1,602,765 QoQ

Shares Held

820,395

+21.6% QoQ

Ownership

0.778%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Aberdeen Group plc holds $1,721,223,490 across 84 Biotechnology names. CRNX ranks #19 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	233,480	$104,258,157
2	REGN	Regeneron Pharmaceuticals, Inc.	121,344	$93,755,226
3	QURE	uniQure N.V.	5,306,386	$86,759,411
4	MANE	Veradermics, Inc	1,054,660	$66,601,779
5	ARGX	Argenx SE	82,106	$59,957,906
6	PCVX	Vaxcyte, Inc.	978,969	$56,887,888
7	PRAX	Praxis Precision Medicines, Inc.	172,484	$55,572,619
8	SRPT	Sarepta Therapeutics, Inc.	2,318,890	$50,459,046

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$29,796,746	820,395	+21.6%	Shares	Defined	2026-04-29
2025-12-31	$31,399,511	674,533	+98.4%	Shares	Defined	2026-01-16
2025-09-30	$14,158,875	339,949	+21.3%	Shares	Defined	2025-11-07
2025-06-30	$8,062,779	280,347	+34.7%	Shares	Defined	2025-07-24
2025-03-31	$6,978,298	208,059	+379.5%	Shares	Defined	2025-05-13
2024-12-31	$2,218,479	43,389	+22.3%	Shares	Defined	2025-01-24
2024-09-30	$1,812,363	35,467	-46.4%	Shares	Defined	2024-10-25
2024-06-30	$2,964,918	66,196	-34.6%	Shares	Defined	2024-08-09
2024-03-31	$4,736,984	101,196	0.0%	Shares	Defined	2024-05-09
2023-12-31	$3,600,553	101,196	—	Shares	Defined	2024-01-31
No filing history on record for this holder in this stock.